Thrombolytics: Difference between revisions

(Text replacement - "Category:Cards" to "Category:Cardiology")
(Text replacement - "Category:Neuro" to "Category:Neurology")
Line 39: Line 39:
==Sources==
==Sources==
<references/>  
<references/>  
[[Category:Cardiology]][[Category:Neuro]]
[[Category:Cardiology]][[Category:Neurology]]

Revision as of 14:14, 22 March 2016

Thrombolytics in STEMI

Alteplase (TPA)

Dosing based on patient weight:

  • 67kg: Infuse 15mg IV over 1-2min; then 50mg over 30min; then 35mg over next 60min (i.e. 100mg over 1.5hr)
  • ≤67kg: Infuse 15mg IV over 1-2min; then 0.75 mg/kg (max 50mg) over 30 min; then 0.5 mg/kg over 60min (max 35 mg)

Tenecteplase (TNKase)

  • Reconstitute 50 mg vial in 10 mL sterile water (5 mg/mL)
  • < 60 kg = 30 mg IV push over 5 seconds
  • 60-69 kg = 35 mg IV push over 5 seconds
  • 70-79 kg = 40 mg IV push over 5 seconds
  • 80-89 kg = 45 mg IV push over 5 seconds
  • > 90 kg = 50 mg IV push over 5 seconds

Indications and Contraindications[1]

  • Indications[2]
    • Chest pain > 30 min but less than 12 hrs, not relieved by NTG
    • PCI greater than 90 min away
    • EKG criteria of STEMI
      • STE in 2 contiguous leads
      • Posterior STEMI
      • LBBB with Sgarbossa criteria
  • Absolute contraindications
    • Prior ICH
    • Known cerebral vascular lesion, AVM
    • Known intracranial malignancy, primary or mets
    • Ischemic stroke within 3 months, but not ischemic stroke within 3 hrs
    • Suspected aortic dissection
    • Active bleeding or bleeding diathesis, excluding menses
    • Significant closed head/facial trauma within 3 months
  • Relative contraindications
    • Hx of chronic, severe HTN
    • SBP > 180 or DBP > 110 mmHg
    • Hx of prior ischemic stroke > 3 months, dementia, or other known intracranial pathology not in absolute contraindications
    • Traumatic CPR or CPR > 10 min
    • Major surgery within 3 wks
    • Internal bleeding within 2-4 wks
    • Noncompressible vascular punctures
    • Prior allergic reactions to fibrinolytics
    • Pregnancy
    • Active PUD
    • Use of anticoagulants

Thrombolysis in Acute Ischemic Stroke (tPA)

Alteplase

  • NOTE - in stroke, do not give aspirin until 24 hours after giving tPA, as ASA with tPA does not improve outcomes and increases bleed risk[3]
  • Do not give acutely heparin (or any anticoagulation) if giving tPA[4]

Dosing:

  • 0.9mg/kg IV (max 90mg total)
    • 10% of dose is administered as bolus; rest is given over 60min
  • Neuro check Q15min x 2hr
  • No anticoagulation/antiplatelets x 24hr
  • Blood pressure (keep SBP <180, DBP <105)

If SBP is >180-230 or DBP is >120:

  • Nicardipine 5 mg/hr by slow infusion (50 mL/hr) initially; may be increased by 2.5 mg/hr every 15 minutes; not to exceed 15 mg/hr OR
  • Labetalol 10mg IV over 1–2 min; repeat dose q10–20min up to 300mg max OR
  • Labetalol 10mg IV followed by infusion at 2–8 mg/min

If BP not controlled by above measures:

  • Nitroprusside 0.5–10mcg/kg/min
  • Continuous arterial monitoring advised
  • Use with caution in patients with hepatic or renal insufficiency

See Also

Sources

  1. Rivera-Bou WL et al. Thrombolytic therapy for acute myocardial infarction. Dec 08, 2015. http://emedicine.medscape.com/article/811234-overview#a3.
  2. ACLS Training Center. Fibrinolytic Checklist for STEMI. https://www.acls.net/images/algo-fibrinolytic.pdf
  3. Zinkstok SM, Roos YB, ARTIS Investigators . Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet (2012) 380(9843):731–7.10.1016/S0140-6736(12)60949-0.
  4. Periprocedural Antithrombotic Treatment During Acute Mechanical Thrombectomy for Ischemic Stroke: A Systematic Review. Rob A. van de Graaf, Vicky Chalos, Gregory J. del Zoppo, Aad van der Lugt, Diederik W. J. Dippel, Bob Roozenbeek. Front Neurol. 2018; 9: 238.